HEADER CHAPERONE 22-OCT-09 2WW7 TITLE FOLDON CONTAINING BETA-TURN MIMIC COMPND MOL_ID: 1; COMPND 2 MOLECULE: FIBRITIN; COMPND 3 CHAIN: A, B, C, D, E, F; COMPND 4 FRAGMENT: FOLDON, RESIDUES 459-484; COMPND 5 SYNONYM: T4 FIBRITIN SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: ENTEROBACTERIA PHAGE T4; SOURCE 4 ORGANISM_TAXID: 10665 KEYWDS D-AMINO ACIDS, CHAPERONE, VIRAL PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR B.ECKHARDT,W.GROSSE,L.-O.ESSEN,A.GEYER REVDAT 2 24-NOV-10 2WW7 1 JRNL REMARK REVDAT 1 29-SEP-10 2WW7 0 JRNL AUTH B.ECKHARDT,W.GROSSE,L.ESSEN,A.GEYER JRNL TITL STRUCTURAL CHARACTERIZATION OF A BETA-TURN MIMIC JRNL TITL 2 WITHIN A PROTEIN-PROTEIN INTERFACE. JRNL REF PROC.NATL.ACAD.SCI.USA V. 107 18336 2010 JRNL REFN ISSN 0027-8424 JRNL PMID 20937907 JRNL DOI 10.1073/PNAS.1004187107 REMARK 2 REMARK 2 RESOLUTION. 1.06 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.5.0102 REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.06 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 26.02 REMARK 3 DATA CUTOFF (SIGMA(F)) : NONE REMARK 3 COMPLETENESS FOR RANGE (%) : 94.22 REMARK 3 NUMBER OF REFLECTIONS : 56886 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.10832 REMARK 3 R VALUE (WORKING SET) : 0.10766 REMARK 3 FREE R VALUE : 0.14024 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 2.0 REMARK 3 FREE R VALUE TEST SET COUNT : 1170 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 1.061 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 1.089 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3629 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 81.85 REMARK 3 BIN R VALUE (WORKING SET) : 0.113 REMARK 3 BIN FREE R VALUE SET COUNT : 65 REMARK 3 BIN FREE R VALUE : 0.159 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2256 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 254 REMARK 3 SOLVENT ATOMS : 447 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 4.41 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 8.441 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -0.57 REMARK 3 B22 (A**2) : 0.18 REMARK 3 B33 (A**2) : 0.14 REMARK 3 B12 (A**2) : 0.29 REMARK 3 B13 (A**2) : 0.28 REMARK 3 B23 (A**2) : 0.06 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.027 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.029 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.017 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 0.711 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.981 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.974 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 1669 ; 0.010 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): 1592 ; 0.003 ; 0.020 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 2323 ; 2.809 ; 2.077 REMARK 3 BOND ANGLES OTHERS (DEGREES): 3578 ; 2.525 ; 3.000 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 202 ; 6.839 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 79 ;29.740 ;21.899 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 291 ;15.425 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 18 ;13.301 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 247 ; 0.153 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 1837 ; 0.007 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): 403 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 932 ; 2.840 ; 3.000 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 352 ; 1.086 ; 3.000 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1563 ; 3.683 ; 4.000 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 737 ; 3.935 ; 3.000 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 739 ; 5.109 ; 4.000 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): 3261 ; 1.968 ; 3.000 REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE REMARK 3 RIDING POSITIONS. U VALUES HAVE BEEN REFINED INDIVIDUALLY. REMARK 4 REMARK 4 2WW7 COMPLIES WITH FORMAT V. 3.20, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 27-OCT-09. REMARK 100 THE PDBE ID CODE IS EBI-41388. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 02-FEB-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID23-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.76990 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 58056 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.06 REMARK 200 RESOLUTION RANGE LOW (A) : 40.00 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.0 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 94.1 REMARK 200 DATA REDUNDANCY : 2.0 REMARK 200 R MERGE (I) : 0.03 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 19.20 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.06 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.12 REMARK 200 COMPLETENESS FOR SHELL (%) : 86.8 REMARK 200 DATA REDUNDANCY IN SHELL : 1.9 REMARK 200 R MERGE FOR SHELL (I) : 0.07 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 9.50 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 1NAY REMARK 200 REMARK 200 REMARK: ONLY THE FOLDON PART OF THE STRUCTURE WAS USED REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 36.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 9 MM POTASSIUM PHOSPHATE, PH REMARK 280 7.0, 10% D2O REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5190 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4230 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.2 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 5130 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 4280 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -7.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: D, F, E REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HOH A 2010 O HOH A 2046 2.08 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 O HOH B 2007 O HOH D 2060 1645 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LYS C 16 CD - CE - NZ ANGL. DEV. = 16.0 DEGREES REMARK 500 ARG D 8 NE - CZ - NH1 ANGL. DEV. = 7.7 DEGREES REMARK 500 ARG D 8 NE - CZ - NH2 ANGL. DEV. = -5.1 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 9 16.02 -141.74 REMARK 500 TH6 A 17 -131.14 50.61 REMARK 500 TH6 B 17 -132.85 49.46 REMARK 500 TH6 C 17 -129.99 61.05 REMARK 500 TH6 D 17 -134.09 49.08 REMARK 500 PRS D 18 38.94 -96.40 REMARK 500 TH6 E 17 -134.84 46.57 REMARK 500 PRS E 18 36.10 -95.81 REMARK 500 TH6 F 17 -132.46 50.34 REMARK 500 PRS F 18 31.93 -97.35 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLU C 19 TRP C 20 148.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CHIRAL CENTERS REMARK 500 REMARK 500 UNEXPECTED CONFIGURATION OF THE FOLLOWING CHIRAL REMARK 500 CENTER(S) USING IMPROPER CA--C--CB--N CHIRALITY REMARK 500 FOR AMINO ACIDS AND C1'--O4'--N1(N9)--C2' FOR REMARK 500 NUCLEIC ACIDS OR EQUIVALENT ANGLE REMARK 500 M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,6X,F5.1,6X,A1,10X,A1,3X,A16) REMARK 500 REMARK 500 M RES CSSEQI IMPROPER EXPECTED FOUND DETAILS REMARK 500 ASP A 9 21.4 L L OUTSIDE RANGE REMARK 500 PRS C 18 54.6 L L OUTSIDE RANGE REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 GAMMA-5R-HYDROXY-THERONINE (TH6): REMARK 600 GAMMA-5R-HYDROXY-THERONINE WAS DIRECTLY LINKED TO PRS VIA REMARK 600 CG FORMING PLICAT REMARK 600 L-THIOPROLINE (PRS): L-THIOPROLINE WAS DIRECTLY LINKED TO REMARK 600 TH6 VIA CD FORMING PLICAT REMARK 700 REMARK 700 SHEET REMARK 700 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2WW6 RELATED DB: PDB REMARK 900 FOLDON CONTAINING D-AMINO ACIDS IN TURN REMARK 900 POSITIONS REMARK 999 REMARK 999 SEQUENCE REMARK 999 G1 WAS DELETED, Y2 WAS REPLACED BY NA8, FOR REMARK 999 G10 A D-AMINO ACID WAS INTRODUCED (DAL), D17 AND G18 WERE REMARK 999 REPLACED BY B-TURN MIMIC DBREF 2WW7 A 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 DBREF 2WW7 B 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 DBREF 2WW7 C 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 DBREF 2WW7 D 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 DBREF 2WW7 E 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 DBREF 2WW7 F 2 27 UNP Q76VI8 Q76VI8_BPT2 459 484 SEQADV 2WW7 NA8 A 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL A 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 A 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS A 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQADV 2WW7 NA8 B 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL B 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 B 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS B 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQADV 2WW7 NA8 C 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL C 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 C 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS C 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQADV 2WW7 NA8 D 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL D 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 D 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS D 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQADV 2WW7 NA8 E 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL E 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 E 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS E 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQADV 2WW7 NA8 F 2 UNP Q76VI8 TYR 459 SEE REMARK 999 SEQADV 2WW7 DAL F 10 UNP Q76VI8 GLY 467 SEE REMARK 999 SEQADV 2WW7 TH6 F 17 UNP Q76VI8 ASP 474 SEE REMARK 999 SEQADV 2WW7 PRS F 18 UNP Q76VI8 GLY 475 SEE REMARK 999 SEQRES 1 A 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 A 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU SEQRES 1 B 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 B 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU SEQRES 1 C 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 C 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU SEQRES 1 D 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 D 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU SEQRES 1 E 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 E 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU SEQRES 1 F 26 NA8 ILE PRO GLU ALA PRO ARG ASP DAL GLN ALA TYR VAL SEQRES 2 F 26 ARG LYS TH6 PRS GLU TRP VAL LEU LEU SER THR PHE LEU MODRES 2WW7 NA8 A 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 A 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS A 18 PRO THIOPROLINE MODRES 2WW7 NA8 B 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 B 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS B 18 PRO THIOPROLINE MODRES 2WW7 NA8 C 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 C 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS C 18 PRO THIOPROLINE MODRES 2WW7 NA8 D 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 D 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS D 18 PRO THIOPROLINE MODRES 2WW7 NA8 E 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 E 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS E 18 PRO THIOPROLINE MODRES 2WW7 NA8 F 2 ALA BETA-(2-NAPHTHYL)-ALANINE MODRES 2WW7 TH6 F 17 THR 4-HYDROXY-L-THREONINE MODRES 2WW7 PRS F 18 PRO THIOPROLINE HET NA8 A 2 50 HET DAL A 10 20 HET TH6 A 17 14 HET PRS A 18 11 HET NA8 B 2 28 HET DAL B 10 10 HET TH6 B 17 14 HET PRS B 18 11 HET NA8 C 2 28 HET DAL C 10 10 HET TH6 C 17 28 HET PRS C 18 22 HET NA8 D 2 28 HET DAL D 10 10 HET TH6 D 17 14 HET PRS D 18 11 HET NA8 E 2 28 HET DAL E 10 10 HET TH6 E 17 14 HET PRS E 18 11 HET NA8 F 2 50 HET DAL F 10 10 HET TH6 F 17 14 HET PRS F 18 11 HETNAM NA8 (1S)-1-CARBOXY-2-NAPHTHALEN-2-YLETHANAMINIUM HETNAM DAL D-ALANINE HETNAM TH6 4-HYDROXY-L-THREONINE HETNAM PRS THIOPROLINE FORMUL 1 NA8 6(C13 H14 N O2 1+) FORMUL 2 DAL 6(C3 H7 N O2) FORMUL 3 TH6 6(C4 H9 N O4) FORMUL 4 PRS 6(C4 H7 N O2 S) FORMUL 5 HOH *447(H2 O) HELIX 1 1 SER A 24 LEU A 27 5 4 HELIX 2 2 SER B 24 LEU B 27 5 4 HELIX 3 3 SER C 24 PHE C 26 5 3 HELIX 4 4 SER D 24 LEU D 27 5 4 HELIX 5 5 SER E 24 LEU E 27 5 4 HELIX 6 6 SER F 24 LEU F 27 5 4 SHEET 1 AA 9 GLU A 19 LEU A 22 0 SHEET 2 AA 9 ALA A 12 LYS A 16 -1 O VAL A 14 N VAL A 21 SHEET 3 AA 9 GLU C 19 LEU C 22 -1 O ARG C 15 N TYR A 13 SHEET 4 AA 9 GLU B 19 LEU B 22 0 SHEET 5 AA 9 ALA B 12 LYS B 16 -1 O VAL B 14 N VAL B 21 SHEET 6 AA 9 GLU A 19 LEU A 22 -1 O ARG A 15 N TYR B 13 SHEET 7 AA 9 GLU C 19 LEU C 22 0 SHEET 8 AA 9 ALA C 12 LYS C 16 -1 O VAL C 14 N VAL C 21 SHEET 9 AA 9 GLU B 19 LEU B 22 -1 O ARG B 15 N TYR C 13 SHEET 1 BA 9 GLU D 19 LEU D 22 0 SHEET 2 BA 9 ALA D 12 LYS D 16 -1 O VAL D 14 N VAL D 21 SHEET 3 BA 9 GLU E 19 LEU E 22 -1 O ARG E 15 N TYR D 13 SHEET 4 BA 9 GLU E 19 LEU E 22 0 SHEET 5 BA 9 ALA E 12 LYS E 16 -1 O VAL E 14 N VAL E 21 SHEET 6 BA 9 GLU F 19 LEU F 22 -1 O ARG F 15 N TYR E 13 SHEET 7 BA 9 GLU F 19 LEU F 22 0 SHEET 8 BA 9 ALA F 12 LYS F 16 -1 O VAL F 14 N VAL F 21 SHEET 9 BA 9 GLU D 19 LEU D 22 -1 O ARG D 15 N TYR F 13 LINK C11 NA8 A 2 N ILE A 3 1555 1555 1.32 LINK C AASP A 9 N ADAL A 10 1555 1555 1.33 LINK C BASP A 9 N BDAL A 10 1555 1555 1.33 LINK C ADAL A 10 N GLN A 11 1555 1555 1.33 LINK C BDAL A 10 N GLN A 11 1555 1555 1.33 LINK C LYS A 16 N TH6 A 17 1555 1555 1.33 LINK CG TH6 A 17 CD PRS A 18 1555 1555 1.53 LINK C TH6 A 17 N PRS A 18 1555 1555 1.33 LINK C PRS A 18 N GLU A 19 1555 1555 1.34 LINK C11 NA8 B 2 N ILE B 3 1555 1555 1.33 LINK C ASP B 9 N DAL B 10 1555 1555 1.34 LINK C DAL B 10 N GLN B 11 1555 1555 1.33 LINK C LYS B 16 N TH6 B 17 1555 1555 1.33 LINK CG TH6 B 17 CD PRS B 18 1555 1555 1.53 LINK C TH6 B 17 N PRS B 18 1555 1555 1.34 LINK C PRS B 18 N GLU B 19 1555 1555 1.33 LINK C11 NA8 C 2 N ILE C 3 1555 1555 1.32 LINK C ASP C 9 N DAL C 10 1555 1555 1.33 LINK C DAL C 10 N GLN C 11 1555 1555 1.33 LINK C LYS C 16 N BTH6 C 17 1555 1555 1.34 LINK C LYS C 16 N ATH6 C 17 1555 1555 1.34 LINK C BTH6 C 17 N BPRS C 18 1555 1555 1.35 LINK CG ATH6 C 17 CD APRS C 18 1555 1555 1.52 LINK CG BTH6 C 17 CD BPRS C 18 1555 1555 1.53 LINK C ATH6 C 17 N APRS C 18 1555 1555 1.34 LINK C BPRS C 18 N BGLU C 19 1555 1555 1.33 LINK C APRS C 18 N AGLU C 19 1555 1555 1.33 LINK C11 NA8 D 2 N ILE D 3 1555 1555 1.32 LINK C ASP D 9 N DAL D 10 1555 1555 1.32 LINK C DAL D 10 N GLN D 11 1555 1555 1.33 LINK C LYS D 16 N TH6 D 17 1555 1555 1.32 LINK C TH6 D 17 N PRS D 18 1555 1555 1.34 LINK CG TH6 D 17 CD PRS D 18 1555 1555 1.52 LINK C PRS D 18 N GLU D 19 1555 1555 1.34 LINK C11 NA8 E 2 N ILE E 3 1555 1555 1.33 LINK C ASP E 9 N DAL E 10 1555 1555 1.33 LINK C DAL E 10 N GLN E 11 1555 1555 1.33 LINK C LYS E 16 N TH6 E 17 1555 1555 1.33 LINK C TH6 E 17 N PRS E 18 1555 1555 1.33 LINK CG TH6 E 17 CD PRS E 18 1555 1555 1.52 LINK C PRS E 18 N GLU E 19 1555 1555 1.32 LINK C11 NA8 F 2 N ILE F 3 1555 1555 1.33 LINK C ASP F 9 N DAL F 10 1555 1555 1.33 LINK C DAL F 10 N GLN F 11 1555 1555 1.33 LINK C LYS F 16 N TH6 F 17 1555 1555 1.33 LINK C TH6 F 17 N PRS F 18 1555 1555 1.34 LINK CG TH6 F 17 CD PRS F 18 1555 1555 1.52 LINK C PRS F 18 N GLU F 19 1555 1555 1.32 CRYST1 27.730 28.500 48.755 77.25 88.00 69.45 P 1 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.036062 -0.013519 0.001797 0.00000 SCALE2 0.000000 0.037472 -0.008562 0.00000 SCALE3 0.000000 0.000000 0.021052 0.00000 MASTER 361 0 24 6 18 0 0 6 0 0 0 12 END